CD34 is a well-known hematopoietic precursor cell marker that has been clinically used to distinguish between acute lymphoblastic leukemia, chronic lymphocytic leukemia, and the leukemic stage (Stage V) of lymphoma (28). Here, CD34 is linked to acute lymphoblastic leukemia.